PTGX Protagonist Therapeutics Inc

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

$7.86  -0.05 (-0.63%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2016
Outstanding shares:  48,656,189
Average volume:  1,253,122
Market cap:   $384,870,455
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDCBCD8
Valuation   (See tab for details)
PE ratio:   -3.12
PB ratio:   1.26
PS ratio:   8.21
Return on equity:   -40.59%
Net income %:   -261.21%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy